Citadel Advisors’s Sunshine Biopharma Inc Warrant SBFMW Stock Holding History

Citadel Advisors’s Portfolio SBFMW Stock Details SBFMW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-12,073	Closed	-$1.66K	–	13890
2025 Q3	$1.66K	Sell	12,073 -8,342	-41%	-$1.68K	﹤0.01%	12591
2025 Q2	$5.31K	Sell	20,415 -10,130	-33%	-$2.61K	﹤0.01%	12227
2025 Q1	$6.16K	Sell	30,545 -10,886	-26%	-$2.44K	﹤0.01%	13770
2024 Q4	$6.67K	Sell	41,431 -3,700	-8%	-$574	﹤0.01%	13784
2024 Q3	$4.96K	Sell	45,131 -23,239	-34%	-$2.37K	﹤0.01%	13529
2024 Q2	$4.79K	Buy	68,370 +1,255	+2%	+$123	﹤0.01%	13458
2024 Q1	$3.24K	Buy	67,115 +5,485	+9%	+$569	﹤0.01%	13926
2023 Q4	$12.9K	Sell	61,630 -4,226	-6%	-$930	﹤0.01%	12959
2023 Q3	$14.8K	Buy	65,856 +34,708	+111%	+$10.8K	﹤0.01%	12857
2023 Q2	$15K	Buy	+31,148	New	+$14K	﹤0.01%	12974

Other funds holding SBFMW

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citadel Advisors's SBFMW Position: Q4 2025 in Review

Citadel Advisors sold out of Sunshine Biopharma Inc Warrant (SBFMW) in Q4 2025, closing a stake of 12,073 shares — an estimated $1.66K sold.

Citadel Advisors first reported a position in SBFMW in Q2 2023 and held it in 10 quarters. The position peaked at $15K in Q2 2023. 1 fund tracked by Wall St. Rank holds SBFMW as of Q4 2025.

Citadel Advisors reported no remaining Sunshine Biopharma Inc Warrant position as of Q4 2025 after selling out during the quarter.
Citadel Advisors sold 12,073 Sunshine Biopharma Inc Warrant shares in Q4 2025, an estimated $1.66K.
Citadel Advisors first reported a position in Sunshine Biopharma Inc Warrant in Q2 2023 and held it in 10 quarters.
Citadel Advisors's Sunshine Biopharma Inc Warrant position peaked at $15K in Q2 2023.
1 fund tracked by Wall St. Rank held Sunshine Biopharma Inc Warrant as of Q4 2025.

Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.